Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 131 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2011  |  Volume : 5  |  Issue : 2  |  Page : 160-163
In vitro function of random donor platelets stored for 7 days in composol platelet additive solution


1 Department of Transfusion Medicine and Blood Bank and Department of Pathology, Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India
2 Department of Transfusion Medicine and Blood Bank, Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India
3 Department of Pathology, Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India

Click here for correspondence address and email

Date of Web Publication28-Jul-2011
 

   Abstract 

Background and Aim: Platelets are routinely isolated from whole blood and stored in plasma for 5 days. This study was done to assess the in vitro function of random donor platelets stored for 7 days in composol platelet additive solution at 22°C. Materials and Methods: The study sample included 30 blood donors of both sex in State Blood Bank, C S M Medical University, Lucknow. Random donor platelets were prepared by the platelet-rich plasma method. Whole blood (350 ml) was collected in anticoagulant Citrate Phosphate Dextrose Adenine triple blood bags. Random donor platelets were stored for 7 days at 22°C in platelet incubators and agitators with and without additive solution. Results: Platelet swirling was present in all the units at 22°C on day 7 with no evidence of bacterial contamination. Comparison of the mean values of platelet count, platelet factor 3, lactate dehydrogenase, pH, glucose and platelet aggregation showed no significant difference in additive solution while platelet factor 3, glucose and platelet aggregation showed significant difference (P < 0.001) on day 7 without additive solution at 22°C. Conclusion: Our study infers that the platelet viability and aggregation were the best maintained within normal levels on day 7 of storage in platelet additive solution at 22°C. Thus, we may conclude that in vitro storage of random donor platelets with an extended shelf life of 7 days using platelet additive solution may be advocated to improve the inventory of platelets.

Keywords: In vitro, random donor platelets, additive solution, storage

How to cite this article:
Gupta A, Chandra T, Kumar A. In vitro function of random donor platelets stored for 7 days in composol platelet additive solution. Asian J Transfus Sci 2011;5:160-3

How to cite this URL:
Gupta A, Chandra T, Kumar A. In vitro function of random donor platelets stored for 7 days in composol platelet additive solution. Asian J Transfus Sci [serial online] 2011 [cited 2018 Sep 26];5:160-3. Available from: http://www.ajts.org/text.asp?2011/5/2/160/83244



   Introduction Top


Platelets are small, anucleated cytoplasmic fragments that play an essential role in blood clotting and wound healing. [1] Platelets are routinely isolated from whole blood and stored in plasma for 5 days. Furthermore, the use of platelet additive solution could help to improve storage conditions and thus increase the shelf-life of the platelets while maintaining viability and hemostatic function. [2],[3] This study was carried out to assess the in vitro function of random donor platelets stored for 7 days in the composol platelet additive solution at 22°C.


   Materials and Methods Top


The study sample included 30 blood donors of both sex in State Blood Bank, Department of Transfusion Medicine, Chhatrapati Shahuji Maharaj Medical University, Lucknow. Complete medical history of donors was obtained to exclude any infection and disease in the collected samples.

Subjects studied

The blood donors were selected after taking a detailed history and a complete examination regarding their eligibility criteria for blood donation. Donor's name, age, sex, occupation, caste, complete postal address, and contact number was obtained. Donors were deferred or accepted according to their medical history regarding chronic or acute diseases. Findings were further confirmed by physical examination of the donor. Blood was taken from a donor only after fulfilling all the eligibility criteria of a healthy donor. Written consent was also obtained from them prior to donation regarding their acceptability for the tests to be carried out for the transfusion transmitted diseases as well for the platelet function studies.

Random donor platelets preparation

Random donor platelets were prepared by the platelet-rich plasma (PRP) method. [4] Whole blood (350 ml) was collected in anticoagulant Citrate Phosphate Dextrose Adenine (CPDA) triple blood bags (HL Hemopack, Hindustan Latex Ltd. Kerala, India). After a resting time of 30 min, whole blood was centrifuged in a Cryofuge 6000i (Heraeus, Germany) at 1750 Χ g for 8 min at 22°C to obtain PRP. The obtained PRP was again centrifuged at 3850 Χ g for 8 min under same experimental conditions. After the final centrifugation, the supernatant PPP was separated, and the residual pellet with the platelets was resuspended in a mean volume of 50 ± 0.9 ml of plasma and remaining 150 ml of plasma was removed. Random donor platelets were divided into two parts by a sterile tubing welder (Terumo TSCD, SC-201 AH, Leuven, Belgium). Four milliliters of additive solution were added in 30 units each of the random donor platelets. The bags were placed in a platelet incubator with agitator (Remi Instruments Ltd., Mumbai, India). Random donor platelets were evaluated on day 0, day 5, and day 7 at 22°C of storage with and without additive solution.

Preparation of random donor platelets using platelet additive solution (Composol)

All the random donor platelets were stored in additive solution which had been standardized using the following constituents: sodium chloride (5.26 g) (Merck Pvt., Ltd., Mumbai, India), sodium gluconate (5.02 g) (Rolex Chemicals Industries, Mumbai, India), sodium acetate anhydrous (2.22 g) (Ranbaxy Fine Chemicals Ltd., New Delhi, India), potassium chloride (0.373 g) (Ranbaxy Fine Chemicals Ltd., New Delhi, India), magnesium chloride hexahydrate (0.305 g) (Merck Pvt., Ltd., Mumbai, India), and sodium citrate (3.213 g) (Sisco Research Pvt., Ltd., Mumbai, India). All the constituents were dissolved in 1000 ml of distilled water, and steam sterilized. The pH of this additive solution was 7.2. [5]

Screening of blood and storage of platelet units

All the blood units were screened for Hepatitis B Virus (Hepalisa, J Mitra and Co. Pvt. Ltd., New Delhi, India), Hepatitis C Virus (HCV Microlisa, J Mitra and Co. Pvt. Ltd., New Delhi, India), and Human Immunodeficiency Virus 1 and 2 (Microlisa-HIV, J Mitra and Co. Pvt. Ltd., New Delhi, India). The method used was enzyme linked immunosorbent assay (Elisa Plate Washer Version 3 and Elisa Plate Reader Version no. 1.300, Robonik Pvt. Ltd., Navi Mumbai, India). Syphilis was tested by the Rapid Plasma Reagin (RPR) method (Span Diagnostic Ltd., Surat, India). Random donor platelets were stored at 22°C in platelet incubators and agitators. Thirty units each of random donor platelets were stored at 22°C with and without additive solution.

Assessment of platelet count and functions

Standard protocols were followed to assess platelets on day 0, day 5, and day 7 of storage. Samples were withdrawn under sterile conditions in biosafety cabinet grade 2. Platelet count was done by automated cell counter (MS4, Blood cell counter, Anand Group, HD Consortium, India). Platelet functions were assessed by Platelet Factor 3 (PF-3) with Kaolin and CaCl 2. [6] An aliquot of 100 μl of platelet-rich test plasma was added to 100 μl of platelet poor normal plasma in a test tube held at 37°C in a water bath. Then, 200 μl of Kaolin was added and stopwatch started. The mixture was incubated for 20 min with occasional shaking and then 200 μl of CaCl was added and clotting time was recorded with a second stopwatch. The procedure was repeated with a mixture of 100 μl of platelet poor test plasma and 100 μl of platelet-rich normal plasma. Lactate dehydrogenase (LDH) determination was conducted on random donor platelets samples: random donor platelets (1 ml) were centrifuged at 3000 Χ g for 5 min. The supernatant was used to quantify the LDH by Semi Automated, Microlab 300 (Merck Specialties Pvt., Ltd., Goa, India). Glucose determination was done by centrifuging 2 ml of random donor platelets in fluoride oxalate vial at 3000 Χ g for 5 min. The supernatant was used to quantify the glucose by Erbachem 5 Plus analyzer (Erba Diagnostic Mannhein Gmbh, Mannhein, Germany). The pH of all samples was assessed immediately after sampling at a temperature of 24°C using the Compla pH meter (Composite Lab Line Pvt. Ltd, Lucknow, India). The platelet aggregation was determined by the optical method [7] using a flat-bottom aggregometer (Chornolog-Corporation, Havertown, PA). The functional study of random donor platelets was performed by the platelet aggregation, using as an agonist 5 μM adenosine di phosphate (ADP) (Amresco, Solon Ind. Pkwy. Solon, OH) at different storage periods. Aerobic culture was performed on all the samples on day 0, day 5, and day 7 using a manual method of culture. [8] The readings at day 5 and day 7 were analyzed taking day 0 as control.

Statistical analysis

Data were reported as means ± standard deviation (SD). The data were compared using paired "t"-test. The confidence limit was kept at 95%, hence a "P" value < 0.05 was considered to be statistically significant.


   Results Top


None of the samples showed bacterial contamination on day 7 at 22°C ± 0.5 with and without additive solution. On comparing the mean values of platelet count in both groups, no significant difference was observed on day 7 of storage period. On assessment of platelet factor 3, no significant difference was seen on day 7 with additive solution. In contrast, a significant difference was observed on day 7 (P < 0.001) without additive solution. The mean values of LDH and pH showed no significant difference on day 7 in both the groups. A significant difference was observed in the levels of glucose on day 7 (P < 0.001) without additive solution. In platelet aggregation, also, a significant decrease was seen without additive solution (P < 0.001) on day 7 at 22°C [Table 1].
Table 1: Comparison the parameters of random donor platelets stored for 7 days at 22°C with and without additive solution

Click here to view



   Discussion Top


Optimized synthetic storage media might help attenuate the platelet storage lesion, thereby facilitating extended storage. Composol contain acetate, which serves as a second metabolic fuel. Acetate has the added benefit of acting as a buffer. Magnesium and potassium are present in Composol. These electrolytes inhibit the platelet activation and aggregation, although how they work is unclear. [9] Potassium plays an important role in maintaining the platelet membrane potential, [10] and, when absent, potassium will leak rapidly from the platelet and needs to be recovered by energy-requiring potassium pumps. Furthermore, it has been shown that the presence of external magnesium activates various potassium pumps. [11] In addition, there is evidence that magnesium decreases the platelet activation [12] and influences the calcium influx into the platelets, thereby having an effect on the intracellular concentration of potassium. [13]

Platelets can be prepared by random donor platelets, apheresis and by pooling of platelet units. [4] Random donor platelets were used in this study. Platelet swirling was present in all the units at a temperature of 22°C with and without additive solution on day 7. No evidence of bacterial contamination was found on day 7 in both groups. In this study, platelet count was maintained on day 7 at 22°C in both the groups.

Shortening of the clotting time of intact PRP, a by incubation with celite or kaolin is believed to result from activation of the Hageman and plasma thromboplastin antecedent (PTA) coagulation factors and from the release of platelet factor 3. It is possible to control the test system so that it is sensitive only to the increase in platelet coagulant activity. [14] Platelet factor 3 may also be released by antiplatelet antibodies. However, the kaolin test has the important advantage of extreme simplicity both in apparatus and in performance. Hence, it is valuable to do a more rigorous standardization of the kaolin test, with an attempt to narrow the observed normal range and thus improve clinical discrimination. The two mixtures (the platelet-rich test plasma and the platelet poor normal plasma) differ only in the platelet they contain and clotting time should not differ by more than 2 or 3 s. A prolongation of the clotting time of the mixture containing the test platelet compared to that containing the normal platelets is the evidence of reduced platelet factor 3 availability. It is desirable to measure the clotting times of mixture of platelet-rich and platelet poor samples of the test plasma and normal plasma, respectively. In this study, the platelet factor 3 variation was within 3 s at 22°C even on day 7 in both the groups. The fact that the platelet fragment can retain their procoagulant activity lends credence to the commonly held theory that the platelet factor 3 generation is dependent on configurational changes of the platelet membrane. [15]

In this study, it was observed that the LDH level slightly increased on day 7 in random donor platelets with and without additive solution and observed that the level of LDH was maintained on day 7 at 22°C. The American Association of Blood Banks (AABB) [16] recommended that platelets with pH < 6.2 should not be used for transfusion, and in Europe the same recommendation applies to platelets with pH > 7.4. [17] As per the Drug and Cosmetics Act of India, [18] the minimum pH should not be <6.0 at any given day of storage. If pH falls below 6.0 or rises 7.4, a disc to sphere transformation of the platelets takes place, resulting in marked loss of recovery in vivo upon transfusion. [19] In this study, we observed that the pH value decreased and maintained within acceptable range on day 7 at 22°C in both groups of storage period. van der Meer et al. [20] made a comparison between two platelet additive solutions: one containing citrate and acetate (PAS-II), the other also supplemented with additional salts such as magnesium, and with gluconate (Composol-PS). The platelet concentrates were prepared by pooling five buffy coats and the additive solution, and the prestorage filtration was utilized to remove leucocytes to well below 1 Χ 10 6 . Storage of platelet concentrates up to 9 days after blood collection revealed that platelet concentrates in Composol-PS maintained an almost constant pH of on average 6.93 from day 2 through day 7, and at 6.90 at day 9. This was in contrast to PAS-II, which showed a gradually decreasing pH from on average 6.97 at day 1 to 6.86 at day 9. In all units stored in both solutions, the swirling effect was present during 9 days of storage. They concluded that both additive solutions allow storage of platelets, derived from pooled buffy coats, for up to 9 days after collection of the whole blood, with the maintenance of good quality in vitro. Composol-PS has a slightly better buffering capacity, reflected as a more constant pH throughout the storage period.

In this study, the glucose level slightly decreased in random donor platelets with and without additive solution on day 7 at 22°C. One of the most common methods of measuring platelet aggregation is called optical platelet aggregation. This technique, which is a high-complexity laboratory test, involves adding an aggregating agent (e.g., ADP, epinephrine, thrombin, arachidonic acid, etc.) to PRP, a turbid platelet-rich suspension derived from whole blood. The effect of the aggregating agent on the suspension's light transmittance is then measured to assess platelet aggregation. [7] In this study, we observed that platelet aggregation were decreased in random donor platelets with and without additive solution on day 7 at 22°C. Kiraly et al. [21] studied the functional viability parameters of single donor platelets for 5 days at room temperature with agitation. They also assessed a number of in vitro parameters (pH, morphology, platelet volume distribution, osmotic recovery, aggregation, and platelet associated IgG) as a function of storage time of platelets. During the first 24 h of storage, minimal changes were observed in the test parameters with the exception of ADP-induced aggregation (75% decrease [10 μM], 84% decrease [5 μM]). A significant difference was observed between the day 0 and day 5 old single donor platelet in all the parameters.

The overall result showed that all the parameters were maintained in random donor platelets stored on 7 day in platelet additive solution at 22°C. van der Meer et al. [22] compared the in vitro storage of characteristics of pooled buffy coat platelet stored for up to 12 days in 100% plasma, or in mixtures of plasma with PAS-II, PAS-III, PAS-III, PAS-IIIM, and Composol. They observed that several in vitro markers of platelet quality (pH ≥ 6.8, glucose consumption, and lactate production) were reasonably well preserved for 9-12 days in platelets stored either in 100% plasma, or in PAS-IIIM (30% plasma), or Composol (35% plasma).


   Conclusion Top


Our study infers that platelet viability and aggregation were best maintained within normal levels on day 7 of storage in platelet additive solution at 22°C. Thus, we may conclude that in vitro quality of random donor platelets is maintained with an extended shelf life of 7 days using platelet additive solution. This forms the basis for increasing the shelf-life of platelets to 7 days from the current guidelines of 5-day storage.


   Acknowledgement Top


We are grateful to the Council of Science and Technology, Uttar Pradesh, Lucknow for funding this work.

 
   References Top

1.Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173-86.  Back to cited text no. 1
    
2.Gulliksson H. Additive solutions for the storage of platelets for transfusion. Transfus Med 2000;10:257-64.  Back to cited text no. 2
    
3.Ringwald J, Walz S, Zimmermann R. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro storage. Vox Sang 2005;89:11-8.  Back to cited text no. 3
    
4.Saran RK. Transfusion medicine technical manual. 2 nd ed. WHO; New Delhi, India; 2003.  Back to cited text no. 4
    
5.Zammit V. In vitro assessment of platelets stored for seven days in a platelet additive medium- a pilot study. Biomed Sci 2006;121:25-32.  Back to cited text no. 5
    
6.Hardisty RM, Hutton RA. The Kaolin Clotting time of PRP: A test of PF-3 availability. Br J Hematol 1965;11:258-60.  Back to cited text no. 6
    
7.Kandice KM. Importance of platelets and platelet response in acute coronary syndromes. Clin J Med 2009;76:S2-S7.  Back to cited text no. 7
    
8.Collee JG, Fraser AG, Marmion BP, Simmons A. Practical medical microbiology. 14 th ed. London: Churchill Livingstone; 1996.  Back to cited text no. 8
    
9.Ringwald J, Zimmermann R, Eckstein R. The new generation of platelet additive solution for storage at 22 degree C: development and current experience. Transfus Med Rev 2006;20:158-64.  Back to cited text no. 9
    
10.Ishikawa Y, Sasakawa S. Membrane potential of stored platelets and its effect on platelet functions. Thromb Res 1987;45:265-73.  Back to cited text no. 10
    
11.Bara M, Guiet-Bara A, Durlach J. Regulation of sodium and potassium pathways by magnesium in cell membranes. Magnes Res 1993;6:167-77.  Back to cited text no. 11
    
12.Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 1994;72:912-8.  Back to cited text no. 12
    
13.Weis-Fogh US. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet membrane. Transfusion 1985;25:339-42.  Back to cited text no. 13
    
14.Spaet TH, Cintron J. Studies on platelet factor-3 availability. Br J Hematol 1965;11:269-75.  Back to cited text no. 14
    
15.Filip DJ, Eckstein JD, Sibley CA. The effect of platelet concentrates storage temperature on adenine nucleotide metabolism. Blood 1975;45:749-6.  Back to cited text no. 15
    
16.Sweeney J. Quality assurance and standards for red cells and platelets. Vox Sang 1998;74:201-5.  Back to cited text no. 16
    
17.Recommendation No. R (95) 15. Guide to the preparation, use and quality assurance of blood components. 7 th ed. Strasbourg, France: European Council Press; 2001. p. 123.  Back to cited text no. 17
    
18.Mallik V. Drug and Cosmetic Act 1940. 13 th ed. Lucknow, India: EBC Publishing Pvt. Ltd; 2001. p. 144-51,243-68.  Back to cited text no. 18
    
19.Murphy S, Gardner FH. Platelet storage at 22°C: Role of gas transport across plastic containers in maintenance of viability. Blood 1975;46:209-12.  Back to cited text no. 19
    
20.van der Meer PF, Pietersz RN, Reesink HW. Comparison of two platelet additive solutions. Transfus Med 2001;11:193-7.  Back to cited text no. 20
    
21.Kiraly TR, Kalish RI, Norton DF. Evaluation of apheresis platelet concentrates stored for 5 days in PL 732 bags. J Clin Apher 2006;3:178-80.  Back to cited text no. 21
    
22.van der Meer PF, Pietersz RN, Reesink HW. In vitro Storage of platelets in additive solution for up to 12 days with maintenance of good quality. Transfusion 2004;44:1204-11.  Back to cited text no. 22
    

Top
Correspondence Address:
Tulika Chandra
Department of Transfusion Medicine and Blood Bank, Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh
India
Login to access the Email id

Source of Support: Council of Science and Technology, Uttar Pradesh, Lucknow, Conflict of Interest: None


DOI: 10.4103/0973-6247.83244

Rights and Permissions



 
 
    Tables

  [Table 1]

This article has been cited by
1 Hemocompatibility of Poly(vinyl alcohol)–Gelatin Core–Shell Electrospun Nanofibers: A Scaffold for Modulating Platelet Deposition and Activation
Valerie M. Merkle,Daniel Martin,Marcus Hutchinson,Phat L. Tran,Alana Behrens,Samir Hossainy,Jawaad Sheriff,Danny Bluestein,Xiaoyi Wu,Marvin J. Slepian
ACS Applied Materials & Interfaces. 2015; 7(15): 8302
[Pubmed] | [DOI]
2 A journey to produce platelets in vitro
Reems, J.-A.
Transfusion. 2011; 51(SUPPL. 4): 169S-176S
[Pubmed]



 

Top
 
  Search

  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusion
   Acknowledgement
    References
    Article Tables

 Article Access Statistics
    Viewed2264    
    Printed172    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Feedback | Copyright and Disclaimer

© 2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006